Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction

American Heart Journal

Volumn 138, Issue 2 II, 1999, Pages

  Colombo, A ^a   Briguori, C ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CORONARY STENT; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SURVIVAL TIME; THROMBOCYTE AGGREGATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032811506     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70336-4     Document Type: Article

References (7)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1986;314:1465-71.
2. Lenderink T, Simoons ML, Van Es GA, et al. Benefit of thrombolytic therapy is sustained throughout 5 years and is related to TIMI perfusion grade 3, but not grade 2 flow at discharge. Circulation 1995;92:1110-6.
3. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
4. GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
5. Nakagawa Y, Iwasaki Y, Kimura T, et al. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction. Am J Cardiol 1996;78:980-4.
6. Horrigan MCG, Topol EJ. Direct angioplasty in acute myocardial infarction: state of the art and current controversies. Cardiol Clin 1995;13:321-38.
7. Stone GW. Primary stenting in acute myocardial infarction. Circulation 1998;97:2482-5.